CIK 0001680581 · Non-accelerated filer<br>Smaller reporting company
Fulcrum Therapeutics, Inc.
Sign in to watch- Ticker
- FULC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474839948
- Phone
- 617-651-8851
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-04 | Gould Robert J Director | Option exercise | +7,235 | $7.84 | $57K | 513,865 |
| 2022-04-04 | Gould Robert J Director | Sale | −7,235 | $24.02 | $174K | 506,630 |
| 2022-04-04 | Gould Robert J Director | Option exercise · Stock Option (right to buy) | −7,235 | 282,763 | ||
| 2022-04-01 | Gould Robert J Director | Option exercise | +34,464 | $7.84 | $270K | 541,094 |
| 2022-04-01 | Gould Robert J Director | Sale | −34,464 | $24.03 | $828K | 506,630 |
| 2022-04-01 | Gould Robert J Director | Option exercise · Stock Option (right to buy) | −34,464 | 289,998 | ||
| 2022-01-19 | Thomson Peter G. VP Finance & Accounting | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-01-19 | Dunn Judith See Remarks | Grant or award · Stock Option (right to buy) | +140,890 | 140,890 | ||
| 2022-01-19 | Stuart Bryan See Remarks | Grant or award · Stock Option (right to buy) | +340,000 | 340,000 | ||
| 2022-01-19 | Morabito Christopher Chief Medical Officer | Grant or award · Stock Option (right to buy) | +59,744 | 59,744 | ||
| 2022-01-19 | Oltmans Curtis Gale SVP, General Counsel | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2022-01-03 | Rajavelu Esther Chief Financial Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2021-12-08 | Banks Sonja Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-11-10 | LEVIN MARK J Director | Other disposition | −1,000,000 | 3,962,202 | ||
| 2019-07-22 | GLAXOSMITHKLINE PLC 10% owner | Conversion | +1,785,714 | 1,785,714 | ||
| 2019-07-22 | GLAXOSMITHKLINE PLC 10% owner | Conversion · Series B Preferred Stock | −12,500,000 | 0 |
Page 7 of 7 · 136 trades